Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ehab Elnakory
Docetaxel, Doxorubicin and Cyclophospharmide as Neoadjuvant Chemotherapy With Primary Prophylactic Stem Cell Growth Factor Support in Locally Advanced Breast Cancer (T3 – T4 , No – 3, Mo)
Research in Oncology
Related publications
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
The Influence of Obesity on Results of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Polski Przeglad Chirurgiczny
Medicine
Surgery
Preoperative High-Dose Chemotherapy With Peripheral Blood Stem Cell Support as a Primary Management of Locally Advanced Breast Cancer
Bone Marrow Transplantation
Transplantation
Hematology
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Prolonged Neoadjuvant Chemotherapy With GM‐CSF in Locally Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer
Genetic Testing and Molecular Biomarkers
Medicine
Genetics
Role of Neoadjuvant Chemotherapy in Locally Advanced Cervical Squamous Cell Cancer
Nihon Gekakei Rengo Gakkaishi (Journal of Japanese College of Surgeons)
Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
The Response, Operability, and Type of Surgery Following Neoadjuvant Chemotherapy in Sudanese Patients With Locally Advanced Breast Cancer
Sudan Journal of Medical Sciences
